Table 3.
Univariate analysis for local control.
| Factor | Patients (n = 57) | 5 Year LC | Univariate Analysis | |
|---|---|---|---|---|
| HR (95% CI) | p-Value | |||
| Age | 0.35 (0.035–3.28) | 0.351 | ||
| ≤75 | 29 | 88.6% | ||
| >75 | 28 | 94.7% | ||
| Gender | 3.04 (0.31–26.41) | 0.337 | ||
| women | 25 | 95.5% | ||
| men | 32 | 88.9% | ||
| Performance status | 0.04 (0.00–6401.09) | 0.596 | ||
| 0 | 47 | 90.4% | ||
| 1–2 | 10 | 100% | ||
| Operability | 0.70 (0.07–6.81) | 0.760 | ||
| operable | 35 | 90.8% | ||
| inoperable | 22 | 95.0% | ||
| Histlogy | 1.50 (0.16–14.43) | 0.726 | ||
| others | 19 | 93.8% | ||
| adenocarcinoma | 38 | 91.1% | ||
| Statge | 6.59 (0.68–63.39) | 0.103 | ||
| IA | 39 | 97.4% | ||
| IB | 18 | 80.5% | ||
| COPD | 5.68 (0.59–54.71) | 0.133 | ||
| no | 35 | 96.3% | ||
| yes | 22 | 84.4% | ||
Abbreviations: LC: local control; HR: hazard ratio; CI: confidential interval; COPD: chronic obstructive pulmonary disease.